Target intelligence / Profile preview

TWIK-related acid-sensitive potassium channel 3 (TASK-3)

Target
TASK-3
Molecular classification
Ion channel, Two-pore domain potassium channel (K2P), Leak potassium channel
01

Overview

TWIK-related acid-sensitive potassium channel 3 (TASK-3) is a member of the two-pore domain potassium channel (K2P) family, encoded by the KCNK9 gene. This ion channel is responsible for “leak” potassium currents that stabilize the resting membrane potential in neuronal and other excitable cells. TASK-3 is sensitive to changes in extracellular pH and can be inhibited by acidification, which induces a unique form of C-type inactivation involving structural rearrangement of the selectivity filter. It is expressed broadly in the central and peripheral nervous systems and also found in some peripheral tissues and the inner mitochondrial membrane. TASK-3 is involved in regulating cell excitability, neurotransmission, and has roles in apoptosis, tumor progression, and neurological disorders. Dysregulation or mutation of TASK-3 is associated with several disease states, including certain cancers, depression, sleep disorders, pain syndromes, and Birk–Barel syndrome. Its pharmacological profile and disease associations make it a promising and increasingly recognized therapeutic target[1][2][4][6][8].

Other names
K2P9.1KCNK9TASK3Potassium channel subfamily K member 9
02

Mechanism of action

Channel inhibition (block of potassium efflux), Channel activation (enhancing leak currents), Allosteric blockade, Inhibition by extracellular acidification, Antibody-mediated inhibition

03

Biological functions

Regulation of resting membrane potentialPotassium ion homeostasisCell excitability modulationSignal transductionRegulation of neurotransmissionApoptosis
04

Disease associations

CancerNeurodegenerative diseaseDepressionPainSleep disordersAnesthetic sensitivityMemory disordersBirk–Barel syndrome
05

Safety considerations

Off-target CNS effects (altered sleep, anesthetic sensitivity, depression risk)On-target toxicity (apoptosis in non-target tissues)Cardiac/pulmonary risk (background role in excitable cells)Potential for neuropsychiatric disturbances
06

Interacting drugs

Doxapram

5 more in the full profile.

07

Biomarkers

Overexpression in certain cancers (e.g., breast cancer, melanoma, gastric cancer)TASK-3 genetic variants in Birk–Barel syndrome

Beyond the preview

Go deeper on TWIK-related acid-sensitive potassium channel 3 (TASK-3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TWIK-related acid-sensitive potassium channel 3 (TASK-3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call